VolitionRx Limited (VNRX) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
VNRX Revenue Growth
VNRX Revenue Analysis (2014–2025)
As of May 8, 2026, VolitionRx Limited (VNRX) generated trailing twelve-month (TTM) revenue of $1.7 million, reflecting explosive growth of +133.2% year-over-year. The most recent quarter (Q4 2025) recorded $447,034 in revenue, down 28.7% sequentially.
Looking at the longer-term picture, VNRX's 5-year compound annual growth rate (CAGR) stands at +164.1%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $1.7 million in 2025, representing a new all-time high.
When compared to Healthcare sector peers including EXAS (+17.7% YoY), ILMN (+1.2% YoY), and NTRA (+35.9% YoY), VNRX has outperformed the peer group in terms of revenue growth. Compare VNRX vs EXAS →
VNRX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| VNRXCurrent | $2M | +133.2% | +164.1% | -1228.6% | |
 EXAS | $3.2B | +17.7% | +16.8% | -6.4% | |
 ILMN | $4.3B | +1.2% | +6.0% | 19.9% | |
 NTRA | $2.3B | +35.9% | +42.6% | -13.4% | |
 GKOS | $507M | +36.3% | +17.7% | -17.1% | |
 GH | $982M | +39.6% | +27.9% | -44.4% |
VNRX Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.7M | +40.0% | $1.7M | 100.0% | $-21,222,056 | -1228.6% |
| 2024 | $1.2M | +59.1% | $1.2M | 100.0% | $-27,024,970 | -2190.9% |
| 2023 | $775K | +153.0% | $775K | 100.0% | $-35,987,695 | -4641.8% |
| 2022 | $306K | +240.3% | $306K | 100.0% | $-31,780,072 | -10372.4% |
| 2021 | $90K | +570.3% | $90K | 100.0% | $-28,333,079 | -31469.0% |
| 2020 | $13K | -21.4% | $13K | 100.0% | $-21,247,815 | -158176.2% |
| 2019 | $17K | - | $17K | 100.0% | $-16,042,924 | -93840.2% |
| 2018 | $0 | - | $-639,916 | - | $-17,897,699 | - |
| 2017 | $0 | - | $-542,484 | - | $-15,045,913 | - |
| 2016 | $0 | - | $-309,406 | - | $-12,266,603 | - |
See VNRX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VNRX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare VNRX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonVNRX — Frequently Asked Questions
Quick answers to the most common questions about buying VNRX stock.
Is VNRX's revenue growth accelerating or slowing?
VNRX revenue is accelerating at +133.2% year-over-year, exceeding the 5-year CAGR of +164.1%. TTM revenue reached $2M. Growth momentum has increased versus prior periods.
What is VNRX's long-term revenue growth rate?
VolitionRx Limited's 5-year revenue CAGR of +164.1% reflects the sustained expansion pattern. Current YoY growth of +133.2% is above this long-term average.
How is VNRX's revenue distributed by segment?
VNRX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.